sameAs
Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990-2013: quantifying the epidemiological transitionUse of angiotensin receptor blockers and risk of dementia in a predominantly male population: prospective cohort analysisFuture directions in Alzheimer's disease from risk factors to preventionWeb-Based Interventions Targeting Cardiovascular Risk Factors in Middle-Aged and Older People: A Systematic Review and Meta-AnalysisApolipoprotein E epsilon4 allele, elevated midlife total cholesterol level, and high midlife systolic blood pressure are independent risk factors for late-life Alzheimer diseaseMidlife vascular risk factors and Alzheimer's disease in later life: longitudinal, population based studyEstimates of global, regional, and national incidence, prevalence, and mortality of HIV, 1980-2015: the Global Burden of Disease Study 2015Stroke: working toward a prioritized world agendaStroke: working toward a prioritized world agendaStroke: working toward a prioritized world agendaNew insights into Alzheimer's disease progression: a combined TMS and structural MRI studyDementia risk in renal dysfunction: A systematic review and meta-analysis of prospective studies.Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013Healthy Ageing Through Internet Counselling in the Elderly: the HATICE randomised controlled trial for the prevention of cardiovascular disease and cognitive impairment.Prevalence of dementia and factors associated with dementia in rural Bangladesh: data from a cross-sectional, population-based study.The Stroke Riskometer(TM) App: validation of a data collection tool and stroke risk predictor.Cholesterol-modifying strategies for Alzheimer's disease.Alzheimer's disease: clinical trials and drug development.Midlife serum cholesterol and increased risk of Alzheimer's and vascular dementia three decades later.Coronary heart disease and cortical thickness, gray matter and white matter lesion volumes on MRIRecruitment and baseline characteristics of participants in the Finnish Geriatric Intervention Study to Prevent Cognitive Impairment and Disability (FINGER)-a randomized controlled lifestyle trialClinical trials and late-stage drug development for Alzheimer's disease: an appraisal from 1984 to 2014Structural MRI in frontotemporal dementia: comparisons between hippocampal volumetry, tensor-based morphometry and voxel-based morphometryMidlife coffee and tea drinking and the risk of late-life dementia: a population-based CAIDE study.Hypertension and hypercholesterolaemia as risk factors for Alzheimer's disease: potential for pharmacological intervention.Epidemiology of Alzheimer's disease: occurrence, determinants, and strategies toward intervention.The influence of multimorbidity on clinical progression of dementia in a population-based cohort.Memantine offers new possibilities for the treatment of VaD.Advances in the prevention of Alzheimer's disease and dementiaMidlife healthy-diet index and late-life dementia and Alzheimer's disease.Risk and protective effects of the APOE gene towards Alzheimer's disease in the Kungsholmen project: variation by age and sex.A voxel based morphometry study on mild cognitive impairment.Advances in the prevention of Alzheimer's Disease.Acetylcholinesterase and its inhibition in Alzheimer disease.Feelings of Hopelessness in Midlife and Cognitive Health in Later Life: A Prospective Population-Based Cohort Study.Metabolome in progression to Alzheimer's disease.Mild cognitive impairment--beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment.CAIDE Dementia Risk Score and biomarkers of neurodegeneration in memory clinic patients without dementia.Clinical trials in mild cognitive impairment: lessons for the future.The Road Ahead to Cure Alzheimer's Disease: Development of Biological Markers and Neuroimaging Methods for Prevention Trials Across all Stages and Target Populations
P50
Q24170269-EF2BBD58-CCF0-47B6-9078-739D1C3400B4Q24646726-071682F0-8596-45AE-BAFA-66B1CADC60F2Q27008518-03EED9BF-DF6F-41E4-869F-29B053CFB90CQ28072511-B61F6828-227C-454C-99C2-37B360157C30Q28216782-417E28A0-E4F3-4A9D-907C-FC5A7880AB7EQ28366850-6F76D801-3747-419D-9E0B-96655470A00BQ28391248-2B0D3AD1-1BA0-424A-9467-EB7536DAF9DBQ28677503-9BDFA6FD-512F-4463-B1A8-6396D3BB33F7Q28677657-E2DF00A8-7BD4-466A-BB27-B6C5DC1A9234Q28742458-D9B47A93-4694-4B07-855F-F671465EF9CAQ28743946-77676F9C-BF35-4F92-9176-DB13B459E11BQ30240101-7287DACA-67FB-4F23-A4FD-D6BED569646BQ30358426-77B04BEC-653F-4BB9-BF7C-BDD4C06C9506Q30489448-7690EADD-6EA4-4089-8B2B-932B71773A23Q30836927-D731F84F-2B4F-44E8-9983-8A39B3C1166FQ30876702-5FBEEFF8-936B-4935-8A8D-FE28A4CFD502Q33347051-CAABEC8C-48E3-4463-BC34-7AFBCD5C4635Q33349401-F5708177-9680-4B76-8A16-E8B71C775BE8Q33621287-3AC954BB-8A05-44D9-AF02-39132E18D920Q34323342-B79341D0-8F77-4E4D-A93B-C4AD36539F3CQ34348190-C3E501F2-62DA-4636-9874-95F096EEFA55Q34408888-5E5E5D29-A0DE-42E4-B99C-187475D63F14Q34534062-61B635C0-75D9-4018-8B59-5924B46987D8Q34603404-10B39E8A-0B56-4259-83D3-79EAF2B8CC8AQ34677568-4B40147C-CEED-43E7-9322-E6168E562FECQ34991223-88A211FF-542E-4776-BE07-80DB4FA747C9Q35080798-B9834E68-B30E-46A7-BDF6-1ADB55233A59Q35172353-76FACFA1-25B5-4217-BC13-05AA4205C243Q35322167-8BB82774-7943-486D-8FA1-4E660453E648Q35428260-2E6B77AD-DC06-4F65-9E59-A827BCEB06E8Q35481029-53CFA616-8994-455C-9CA0-C54E98363E70Q35483542-E5588F76-D634-4C73-A580-610821875B53Q35659387-2EA59F34-35F2-4953-8DFA-38363A382CC4Q35800622-A7766B3D-E8B0-416D-8F43-E5B93EE00197Q35804604-62AF03FA-FD53-41F7-8D33-8108C1DD8850Q35844155-06D83E9A-7504-4673-888E-4A6ABBEB7D94Q35868499-7991C829-B0CA-4E6A-9078-F40DD12C8F2DQ36008217-6A88DBF7-0A59-48F4-9C07-019B41B8B569Q36142255-B0A2B5A5-38DD-453D-B69B-C7814177C012Q36165011-BD475A86-3636-4CC6-8514-4CBB098297B8
P50
description
Finnish neurologist
@en
Finnish neurologist
@en-ca
Finnish neurologist
@en-gb
neuróloga finlandesa
@es
طبيبة أعصاب فنلندية
@ar
name
Miia Kivipelto
@ast
Miia Kivipelto
@ca
Miia Kivipelto
@de
Miia Kivipelto
@en
Miia Kivipelto
@es
Miia Kivipelto
@fi
Miia Kivipelto
@fr
Miia Kivipelto
@ga
Miia Kivipelto
@nl
Miia Kivipelto
@sl
type
label
Miia Kivipelto
@ast
Miia Kivipelto
@ca
Miia Kivipelto
@de
Miia Kivipelto
@en
Miia Kivipelto
@es
Miia Kivipelto
@fi
Miia Kivipelto
@fr
Miia Kivipelto
@ga
Miia Kivipelto
@nl
Miia Kivipelto
@sl
prefLabel
Miia Kivipelto
@ast
Miia Kivipelto
@ca
Miia Kivipelto
@de
Miia Kivipelto
@en
Miia Kivipelto
@es
Miia Kivipelto
@fi
Miia Kivipelto
@fr
Miia Kivipelto
@ga
Miia Kivipelto
@nl
Miia Kivipelto
@sl
P1153
6701347410
P1651
dnL6bYfrJdQ
P19
P21
P27
P31
P496
0000-0003-0992-3875
P569
1973-01-01T00:00:00Z